Perpetual Ltd Decreases Holdings in Intuitive Surgical, Inc. $ISRG

Perpetual Ltd reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 99.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 857 shares of the medical equipment provider’s stock after selling 101,199 shares during the period. Perpetual Ltd’s holdings in Intuitive Surgical were worth $383,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Tobam raised its holdings in shares of Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 40 shares during the period. Kilter Group LLC acquired a new stake in Intuitive Surgical in the second quarter valued at approximately $27,000. Princeton Global Asset Management LLC acquired a new stake in Intuitive Surgical in the second quarter valued at approximately $30,000. TD Capital Management LLC raised its stake in shares of Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares during the period. Finally, 1248 Management LLC acquired a new position in shares of Intuitive Surgical during the first quarter worth $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $572.47 on Monday. The company has a market capitalization of $205.22 billion, a price-to-earnings ratio of 75.72, a price-to-earnings-growth ratio of 5.26 and a beta of 1.68. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The stock has a 50-day simple moving average of $541.48 and a 200 day simple moving average of $505.61.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The company had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same quarter last year, the business posted $1.84 EPS. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Truist raised its price target to $650 and maintains a Buy rating — the upgrade gives visible upside and likely underpins analyst-driven buying interest. Read More. Read More.
• Positive Sentiment: RBC publishes a bullish forecast and RBC Capital keeps an Outperform rating — another large broker calling for strong price appreciation, supporting momentum. Read More. Read More.
• Positive Sentiment: Robert W. Baird reaffirmed its Buy rating — adds to the cluster of brokerages staying constructive, which can sustain inflows. Read More.
• Positive Sentiment: ISRG received a mention on CNBC’s “Final Trades” — media highlights can drive short-term retail/intraday interest. Read More.
• Neutral Sentiment: Company reorganized its digital and AI leadership (effective Jan 1) — signals focus on software/AI strategy but execution and timing are uncertain. Read More.
• Neutral Sentiment: ISRG plans to move to direct distribution in Southern Europe in 2026 to capture distributor economics — could lift margins if executed well, but the analyst note flags execution risk. Read More.
• Neutral Sentiment: Analyst consensus remains a “Moderate Buy” across brokerages — broad support, but not unanimous conviction; reinforces the view of steady analyst backing. Read More.
• Negative Sentiment: Valuation questions after a ~27% three‑month share-price climb — coverage is asking whether ISRG is still undervalued, raising the risk of short-term profit-taking given elevated multiples. Read More.

Insider Activity

In other Intuitive Surgical news, SVP Mark Brosius sold 4,500 shares of Intuitive Surgical stock in a transaction on Friday, December 12th. The shares were sold at an average price of $547.36, for a total value of $2,463,120.00. Following the completion of the transaction, the senior vice president owned 907 shares of the company’s stock, valued at $496,455.52. The trade was a 83.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Henry L. Charlton sold 13,731 shares of the business’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the sale, the executive vice president owned 3,056 shares of the company’s stock, valued at approximately $1,772,480. The trade was a 81.80% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 114,007 shares of company stock valued at $63,533,844 over the last three months. 0.70% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on ISRG shares. Hsbc Global Res raised shares of Intuitive Surgical to a “strong-buy” rating in a report on Thursday, October 23rd. Wall Street Zen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. Wells Fargo & Company raised their target price on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Rothschild & Co Redburn lifted their target price on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Finally, UBS Group set a $600.00 price target on Intuitive Surgical and gave the company a “neutral” rating in a report on Thursday, October 23rd. Two analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $611.08.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.